In May, the U.S. Senate approved Sinema’s bipartisan legislation designating July 20, 2022 as National Glioblastoma Awareness Day
WASHINGTON – Arizona senior Senator Kyrsten Sinema honored the late Arizona Senator John McCain, who passed away in 2018 from glioblastoma, and other Americans who have battled and continue to battle brain cancer on National Glioblastoma Awareness Day.
In May, the U.S. Senate unanimously approved Sinema’s bipartisan legislation designating July 20, 2022 as National Glioblastoma Awareness Day.
“Today we’re honoring John McCain – my personal hero – and thousands of Americans who have battled or continue to battle glioblastoma. We’re raising awareness and strengthening efforts towards finding a cure and developing new treatments for this disease and other brain cancers,” said Sinema.
“Now in its fourth year, Glioblastoma Awareness Day is made possible because of a bipartisan, bicameral commitment to shine a light on this devastating disease,” said David Arons, chief executive officer of the National Brain Tumor Society (NBTS). “Glioblastoma is among the toughest cancers on the planet, and we greatly appreciate congressional champions like Senator Sinema coming together and helping NBTS create this day to honor everyone who has faced GBM. It will take stakeholders from across the country working together to create the change we desperately need to defeat GBM, and congressional Glioblastoma Awareness Day efforts set a significant example of how partnership across divides can bring us one step closer to conquering and curing glioblastoma.”
Each year, over 13,000 Americans are diagnosed with glioblastomas, and 10,000 Americans tragically die from these brain tumors. Sinema’s bipartisan legislation calls for treatments of glioblastoma and related brain cancers to slow its progression, improve quality of life, and recognize the importance of molecular biomarker testing to improve diagnosis and treatment.